Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PET/X

PET/X
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$275K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of breast cancer diagnosis system designed to detect cancer and avoid delays. The company combines positron emmision tomography and X-ray mammography to determine which targeted breast cancer therapies will be effective for each patient, enabling physicians to offer targeted treatment for cancer and improve patient health.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 4000 Mason Road
  • Suite 300
  • Seattle, WA 98195
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PET/X’s full profile, request a free trial.

PET/X Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2013 $275K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PET/X Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
University of Washington University 000 0000 000000 0
UW CoMotion Labs Accelerator/Incubator 000 0000 000000 0

PET/X Executive Team (3)

Name Title Board
Seat
Contact
Info
William Hunter Ph.D Chief Executive Officer & Chief Scientific Officer
Lawrence Macdonald Ph.D Co-Founder
Paul Kinahan Ph.D Co-Founder